The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Management of venous port systems in oncology: a review of current evidence
Open accessAbstract
Background Over the last decades, many changes have occurred in oncology with new chemotherapy combinations and more complex application schemes becoming available. Central venous catheters and implantable venous port systems have become widely used and have facilitated the problem of vascular access. However, important complications are associated with permanent central venous catheters.Material and methods This review summarizes evidence on venous port system use published in Medline up to February 2007. Moreover, recent guidelines for the prevention and management of catheter-related infections issued by the Infectious Diseases Society of America, the American College of Critical Care Medicine, the Society for Healthcare Epidemiology of America, the Center for Disease Control and Prevention, Atlanta, and the Infectious Diseases Working Party of the German Society of Hematology and Oncology are included.Results Sterile precautions are essential when implanting and accessing port systems. Infections must be treated with adequate antimicrobial therapy. Catheter-related thromboembolic complications were found at a rate of 12-64% in retrospective studies. Five current clinical trials investigated the effect of prophylactic anticoagulation with either low molecular weight heparin or warfarin in cancer patients with central venous devices. On the basis of these results, routine anticoagulation cannot be recommended.Conclusions This article reviews the current literature on long-term complications of venous port systems, focusing on infection and thrombosis. In addition, it summarizes the evidence regarding routine maintenance of port systems in follow-up care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The access required for intravenous infusions, the standard administration route for biologic drugs in oncology, involves invasive procedures that can be inconvenient and painful and a drain on the time and resources of patients, healthcare professionals (HCPs), and the healthcare system in general [2–4].”
From Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities (2018) · cites this paper as [3]
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O’Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J. L., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,727
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 787
Complications and Failures of Subclavian-Vein Catheterization
Mansfield, P. F., Hohn, D. C., Fornage, B. D., Gregurich, M. A., & Ota, D. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412293312602 · Cited by 709
A modified right atrial catheter for access to the venous system in marrow transplant recipients.
Hickman, R. O., Buckner, C. D., Clift, R. A., Sanders, J. E., STEWART, P. S., & Thomas, E. D. (1979) · PubMed · Cited by 647
Complications and Failures of Subclavian-Vein Catheterization
Mansfield, P. F., Höhn, D., Fornage, B. D., Gregurich, M. A., & Ota, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322313 · Cited by 626
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso, M., & Agnelli, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.008 · Cited by 611
A silicone rubber atrial catheter for prolonged parenteral alimentation.
Broviac, J. W., Cole, J. J., & Scribner, B. H. (1973) · PubMed · Cited by 550
Niederhuber, J. E., Ensminger, W. D., Gyves, J. W., Liepman, M., Doan, K., & Cozzi, E. (1982) · PubMed · Cited by 513
Cited by
Sorted by citations
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs · doi:10.1007/s40259-018-0295-0 · Cited by 447
Vascular Access in Oncology Patients
Gallieni, M. A., Pittiruti, M., & Biffi, R. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2008.0015 · Cited by 285
Biffi, R., Orsi, F., Pozzi, S., Pace, U., Bonomo, G., Monfardini, L., Vigna, P. D., Rotmensz, N., Radice, D., Zampino, M. G., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn701 · Cited by 237
Central venous access in oncology: ESMO Clinical Practice Guidelines
Sousa, B., Furlanetto, J., Hutka, M., Gouveia, P. F., Wuerstlein, R., Mariz, J., Pinto, D., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv296 · Cited by 198
Lebeaux, D., Fernández‐Hidalgo, N., Chauhan, A., Lee, S. J., Ghigo, J., Almirante, B., & Beloin, C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70266-4 · Cited by 193
Venous Access Ports: Indications, Implantation Technique, Follow-Up, and Complications
Walser, E. (2011) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-011-0271-2 · Cited by 174
Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
Shpilberg, O., & Jackisch, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.371 · Cited by 138
Debourdeau, P., Chahmi, D. K., Gal, G. L., Kriegel, I., Desruennes, É., Douard, M. C., Elalamy, I., Meyer, G., Mismetti, P., Pavic, M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp052 · Cited by 135
Narducci, F., Jean-Laurent, M., Boulanger, L., Bedoui, S. E., Mallet, Y., Houpeau, J.-L., Hamdani, A. R. T., Penel, N., & Fournier, C. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.06.016 · Cited by 127
Bonizzoli, M., Batacchi, S., Cianchi, G., Zagli, G., Lapi, F., Tucci, V., Martini, G., Valvasone, S. D., & Peris, A. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-2043-x · Cited by 116
Focus on peripherally inserted central catheters in critically ill patients
Cotogni, P. (2014) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v3.i4.80 · Cited by 112
Infection of totally implantable venous access devices: A review of the literature
Pinelli, F., Cecero, E., Degl’Innocenti, D., Selmi, V., Giua, R., Villa, G., Chelazzi, C., Romagnoli, S., & Pittiruti, M. (2018) · The Journal of Vascular Access · doi:10.1177/1129729818758999 · Cited by 106
Chauhan, A., Lebeaux, D., Ghigo, J., & Beloin, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01606-12 · Cited by 93
Analysis of risk factors for central venous port failure in cancer patients
Hsieh, C., Weng, H., Huang, W.-S., Wang, W.-K., Kao, C., Lu, M., & Wang, C. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4709 · Cited by 89
Fang, S., Yang, J., Song, L., Jiang, Y., & Liu, Y. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s142556 · Cited by 86
Implantation of 3951 Long-Term Central Venous Catheters
Peris, A., Zagli, G., Bonizzoli, M., Cianchi, G., Ciapetti, M., Spina, R., Anichini, V., Lapi, F., & Batacchi, S. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f333c1 · Cited by 82
Epidemiology, risk and outcomes of venous thromboembolism in cancer
Russo, L., & Falanga, A. (2011) · Hämostaseologie · doi:10.5482/ha-1170 · Cited by 78
Clinical Outcome After a Totally Implantable Venous Access Port-Related Infection in Cancer Patients
Lebeaux, D., Larroque, B., Gellen‐Dautremer, J., Leflon‐Guibout, V., Dreyer, C., Bialek-Davenet, S., Froissart, A., Hentic, O., Tessier, C., Ruimy, R., et al. (2012) · Medicine · doi:10.1097/md.0b013e318275ffe1 · Cited by 76
Kim, H. J., Yun, J., Kim, H. J., Kim, K. H., Kim, S. H., Lee, S., Bae, S. B., Kim, C. K., Lee, N. S., Lee, K. T., et al. (2010) · Journal of Korean Medical Science · doi:10.3346/jkms.2010.25.12.1748 · Cited by 71
Molin, A. D., Rasero, L., Guerretta, L., Perfetti, E., & Clerico, M. A. (2010) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2010.11.007 · Cited by 66
Park, L. C., Woo, S., Kim, S., Jeon, H., Ko, Y. H., Kim, S. J., & Kim, W. S. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.03.019 · Cited by 66
MA, L., Liu, Y., WANG, J., CHANG, Y., Yu, L., & Geng, C. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.726 · Cited by 65
Burcombe, R., Chan, S., Simcock, R., Samanta, K., Percival, F., & Barrett-Lee, P. (2013) · Advances in Breast Cancer Research · doi:10.4236/abcr.2013.24022 · Cited by 59
Anticancer treatment and thrombosis
Falanga, A., & Marchetti, M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.10.025 · Cited by 58
Solinas, G., Platini, F., Trivellato, M., Rigo, C., Alabiso, O., & Galetto, A. (2017) · The Journal of Vascular Access · doi:10.5301/jva.5000740 · Cited by 57
Randomised comparison of complications from three different permanent central venous access systems
Vandoni, R. E., Guerra, A., Sanna, P., Bogen, M., Cavalli, F., & Gertsch, P. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12523 · Cited by 57
Karanlık, H., Kurul, S., Saip, P. M., Unal, E. S., Şen, F., Dişçi, R., & Topuz, E. (2011) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.05.005 · Cited by 56
Busch, J. D., Herrmann, J., Heller, G. F., Derlin, T., Koops, A., Adam, G., & Habermann, C. R. (2012) · American Journal of Roentgenology · doi:10.2214/ajr.11.7970 · Cited by 54
Falanga, A. (2009) · Cancer Investigation · doi:10.1080/07357900802563028 · Cited by 53
Infections Caused by Percutaneous Intravascular Devices
Beekmann, S. E., & Henderson, D. K. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00302-7 · Cited by 51
Flushing the Central Venous Catheter: Is Heparin Necessary?
Molin, A. D., Allara, E., Montani, D., Milani, S., Frassati, C., Cossu, S., Tonella, S., Brioschi, D., & Rasero, L. (2014) · The Journal of Vascular Access · doi:10.5301/jva.5000225 · Cited by 51
Goltz, J. P., Scholl, A., Ritter, C. O., Wittenberg, G., Hahn, D., & Kickuth, R. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-010-9854-6 · Cited by 50
Chen, I., Hsu, C., Chen, Y., Chien, S.-F., Kao, H., Chang, S., Hu, F., & Yeh, K. (2012) · Annals of Oncology · doi:10.1093/annonc/mds468 · Cited by 45
Mori, Y., Nagayama, S., Kawamura, J.-I., Hasegawa, S., Tanaka, E. I., Okabe, H., Takeuchi, M., Sonobe, M., Matsumoto, S., Kanai, M., et al. (2015) · International Journal of Clinical Oncology · doi:10.1007/s10147-015-0917-1 · Cited by 44
Venous Access Ports: Frequency and Management of Complications in Oncology Patients
Jordan, K., Behlendorf, T., Surov, A., Kegel, T., Maher, G., & Wolf, H. (2008) · Onkologie · doi:10.1159/000140451 · Cited by 43
Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer
Kawamura, J., Nagayama, S., Nomura, A., Itami, A., Okabe, H., Sato, S., Watanabe, G., & Sakai, Y. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0766-2 · Cited by 41
Ryan, S., North, R., Harvey, V. J., & Cox, L. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s85599 · Cited by 41
Molin, A. D., Clerico, M. A., Baccini, M., Guerretta, L., Sartorello, B., & Rasero, L. (2015) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2015.04.001 · Cited by 39
Wu, S., Huang, J., Jiang, Z., Huang, Z., Ouyang, H., Deng, L., Lin, W., Guo, J. Y., & Zeng, W. (2016) · BMC Cancer · doi:10.1186/s12885-016-2791-2 · Cited by 38
Biffi, R., Pozzi, S., Bonomo, G., Vigna, P. D., Monfardini, L., Radice, D., Rotmensz, N., Zampino, M. G., Fazio, N., & Orsi, F. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3784-5 · Cited by 37
LeVasseur, N., Stober, C., Daigle, K., Robinson, A., McDiarmid, S. A., Mazzarello, S., Hutton, B., Joy, A. A., Fergusson, D. A., Hilton, J. F., et al. (2018) · Current Oncology · doi:10.3747/co.25.3903 · Cited by 37
Tsuruta, S., Goto, Y., Miyake, H., Nagai, H., Yoshioka, Y., Yuasa, N., & Takamizawa, J. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05122-3 · Cited by 36
Phase II Trial on Extending the Maintenance Flushing Interval of Implanted Ports
Diaz, J. A., Rai, S. N., Wu, X., Chao, J.-H., Dias, A., & Kloecker, G. H. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.010843 · Cited by 35
Xu, H., Chen, R., Jiang, C., You, S., Zhu, Q., Li, Y., Li, S., Zha, X., & Wang, J. (2019) · The Journal of Vascular Access · doi:10.1177/1129729819894461 · Cited by 35
Jiang, M., Li, C.-L., Pan, C., Cui, X., & Dietrich, C. F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14930 · Cited by 35
Outcome of totally implantable venous-access port-related infections
Vidal, M., Genillon, J. P., Forestier, E., Trouiller, S., Pereira, B., Mrozek, N., Auméran, C., & Lesens, O. (2016) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2015.12.006 · Cited by 35
Nurses' knowledge regarding the handling of the totally-implanted venous access device
Pires, N. N., & Vasques, C. I. (2014) · Texto & Contexto - Enfermagem · doi:10.1590/0104-07072014000830013 · Cited by 33
Chang, Y.-F., Lo, A., Tsai, C., Lee, P.-Y., Sun, S., Chang, T. H., Chen, C.-C., Chang, Y.-S., & Chen, J. (2011) · Palliative Medicine · doi:10.1177/0269216311428777 · Cited by 32
Zhou, J., Qian, S., He, W., Han, G., Li, H., & Luo, R. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-378 · Cited by 32
Carraro, F., Cicalese, M. P., Cesaro, S., Santis, R. D., Zanazzo, G. A., Tornesello, A., Giordano, P., Bergadano, A., & Giacchino, M. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1794-1 · Cited by 30
Palese, A., Baldassar, D., Rupil, A., Bonanni, G., Maria, T. C., Contessi, D., Crignis, L. D., Vidoni, A., Piller Roner, S., & Zanini, A. (2013) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2013.09.002 · Cited by 29
Clemons, M. J., Stober, C., Kehoe, A., Bedard, D., MacDonald, F., Brunet, M.-C., Saunders, D., Vandermeer, L., Mazzarello, S., Awan, A. A., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05326-y · Cited by 28
Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children
Gloria González, G., Davidoff, A. M., Howard, S. C., Pui, C., Rao, B. N., Shenep, J. L., Wozniak, A. W., & Shochat, S. J. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.24010 · Cited by 28
Port Catheter Insufficiency: Incidence and Clinical-Radiological Correlations
Surov, A., Jordan, K., Buerke, M., Arnold, D., John, E., Spielmann, R., & Behrmann, C. (2008) · Onkologie · doi:10.1159/000140454 · Cited by 27
Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes
Bildstein, L., Pili, B., Marsaud, V., Wack, S., Meneau, F., Lepêtre‐Mouelhi, S., Desmaële, D., Bourgaux, C., Couvreur, P., & Dubernet, C. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.003 · Cited by 26
State of the Science of Oncology Vascular Access Devices
Camp-Sorrell, D. (2010) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2010.02.001 · Cited by 26
Antibiotic prophylaxis in the placement of totally implanted central venous access ports
Scaife, C. L., Gross, M. E., Mone, M. C., Hansen, H. J., Litz, C. L., Nelson, E. T., Anderson, C. J., Wagner, G. E., Gawlick, U., & Nelson, E. W. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2010.07.023 · Cited by 26
Complications after implantation of subcutaneous central venous ports (PowerPort®)
Nakamura, T., Sasaki, J., Asari, Y., Sato, T., Torii, S., & Watanabe, M. (2017) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2017.03.014 · Cited by 25
Tippit, D., Siegel, E. R., Ochoa, D., Pennisi, A., Hill, E. L., Merrill, A. Y., Rowe, M., Henry‐Tillman, R., Ananthula, A., & Makhoul, I. (2018) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223418771909 · Cited by 25
Sugawara, S., Sone, M., Sakamoto, N., Sofue, K., Hashimoto, K., Arai, Y., Tokue, H., Takigawa, M., Mimura, H., Yamanishi, T., et al. (2023) · Interventional Radiology · doi:10.22575/interventionalradiology.2022-0015 · Cited by 24
Complications infectieuses liées aux chambres implantables : caractéristiques et prise en charge
Lebeaux, D., Zarrouk, V., Leflon‐Guibout, V., Lefort, A., & Fantin, B. (2010) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2010.06.014 · Cited by 25
Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center
Ji, L., Yang, J., Miao, J., Shao, Q., Cao, Y., & Li, H. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0443-1 · Cited by 25
Management of the Cancer Patient With Infection and Neutropenia
Rapoport, B. L. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.03.013 · Cited by 23
A Retrospective Clinical Study: Complications of Totally Implanted Central Venous Access Ports
Seok, J., Kim, Y. J., Cho, H. M., Ryu, H. Y., Hwang, W. J., & Sung, T. Y. (2014) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/kjtcs.2014.47.1.26 · Cited by 23
Experience in totally implantable venous port catheter: Analysis of 3,000 patients in 12 years
Yanık, F. (2018) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2018.15299 · Cited by 23
Matsushima, H., Adachi, T., Iwata, T., Hamada, T., Moriuchi, H., Yamashita, M., Kitajima, T., Okubo, H., & Eguchi, S. (2016) · Journal of surgical education · doi:10.1016/j.jsurg.2016.11.005 · Cited by 22
Thiel, K., Kalmbach, S., Maier, G., Wichmann, D., Schenk, M., Königsrainer, A., & Thiel, C. (2022) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-022-02656-9 · Cited by 21
Effect of port-care frequency on venous port catheter-related complications in cancer patients
Odabaş, H., Özdemir, N., Zıraman, İ., Aksoy, S., Abalı, H., Öksüzoğlu, B. Ç., Isik, M., Civelek, B., Dede, D., & Zengin, N. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-013-0609-7 · Cited by 21
Insertion of Totally Implantable Central Venous Access Devices by Surgeons
An, H., Ryu, C.-G., Jung, E.-J., Kang, H. J., Paik, J. H., Yang, J.-H., & Hwang, D. (2015) · Annals of Coloproctology · doi:10.3393/ac.2015.31.2.63 · Cited by 21
Pulmonary Artery Pseudoaneurysm After a Vascular Access Port Catheter Implantation
Öz, K., Demirhan, R., Onan, B., & Sancakli, I. (2008) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2008.05.061 · Cited by 21
Fornaro, C., Piubeni, M., Tovazzi, V., Cosentini, D., Gelmi, M., Rota, G., Berta, B., Barucco, W., Lombardi, E., Moles, L., et al. (2018) · European Journal of Cancer Care · doi:10.1111/ecc.12978 · Cited by 20
Wu, X., Zhang, T., Chen, L., & Chen, X. (2020) · The Journal of Vascular Access · doi:10.1177/1129729820950998 · Cited by 20
Biffi, R., Orsi, F., Pozzi, S., Maldifassi, A., Radice, D., Rotmensz, N., Zampino, M. G., Fazio, N., Peruzzotti, G., & Didier, F. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0984-9 · Cited by 20
Lapalu, J., Losser, M.-R., Albert, O., Levert, H., Villiers, S., Faure, P., & Douard, M.-C. (2010) · The Journal of Vascular Access · doi:10.1177/112972981001100110 · Cited by 20
Application and comparison of different implanted ports in malignant tumor patients
Li, Y., Cai, Y., Gan, X., Ye, X., Ling, J., Kang, L., Ye, J., Zhang, X., Zhang, J., Cai, Y., et al. (2016) · World Journal of Surgical Oncology · doi:10.1186/s12957-016-1002-6 · Cited by 20
Oh, S.-B., Park, K., Kim, J., Oh, S.-Y., Jung, K.-S., Park, B.-S., Son, G. M., Kim, H., Kim, D. H., Jung, H.-J., et al. (2021) · Medicine · doi:10.1097/md.0000000000024156 · Cited by 20
Crisinel, M., Mahy, S., Ortega‐Deballon, P., Buisson, M., Favre, J.-P., Chavanet, P., & Piroth, L. (2008) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2008.11.004 · Cited by 19
İlhan, B., Sormaz, İ. C., & Türkay, R. (2018) · The Korean Journal of Thoracic and Cardiovascular Surgery · doi:10.5090/kjtcs.2018.51.5.333 · Cited by 19
Clari, M., Spoto, M., Franceschi, G., Acuto, M., Tonella, S., Caristia, S., Buratti, G., Gaboardi, S., Rasero, L., Campagna, S., et al. (2020) · Cancer Nursing · doi:10.1097/ncc.0000000000000819 · Cited by 19
Tümay, V., & Güner, O. S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05871-6 · Cited by 19
Management of Non-Infectious Central Venous Access Device Complications
Schulmeister, L. (2010) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2010.02.003 · Cited by 18
Late complications of totally implantable venous access ports in patients with cancer
Yu, X., Xu, J.-L., Li, D., & Jiang, Z. (2018) · Medicine · doi:10.1097/md.0000000000012427 · Cited by 18
Molin, A. D., Massimo, D. S. D., Braggion, C., Bisogni, S., Rizzi, E., D’Orazio, C., Toppa, M. V. D., Alghisi, F., Cristadoro, S., Carnovale, V., et al. (2012) · The Journal of Vascular Access · doi:10.5301/jva.5000036 · Cited by 18
Fonseca, I. Y. I., Krutman, M., Nishinari, K., Yazbek, G., Teivelis, M. P., Bomfim, G. A. Z., Cavalcante, R. N., & Wolosker, N. (2016) · Einstein (São Paulo) · doi:10.1590/s1679-45082016ao3606 · Cited by 18
Catalano, O., di Castelguidone, E. D. L., Sandomenico, C., Petrillo, M., Aprea, P., Granata, V., & D'Errico, A. G. (2011) · Acta Radiologica · doi:10.1258/ar.2010.100294 · Cited by 18
Berardi, R., Rinaldi, S., Santini, D., Vincenzi, B., Giampieri, R., Maccaroni, E., Marcucci, F., Francoletti, M., Onofri, A., Lucarelli, A., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2466-y · Cited by 18
El‐Balat, A., Schmeil, I., Karn, T., Holtrich, U., Mavrova-Risteska, L., Rody, A., Youssef, A., & Hanker, L. (2018) · In Vivo · doi:10.21873/invivo.11377 · Cited by 18
Self-citationJons, C. K., Prossnitz, A. N., Eckman, N., Dong, C., Utz, A., & Appel, E. A. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv6427 · Cited by 19
Hitz, F., Klingbiel, D., Omlin, A. G., Riniker, S., Zerz, A., & Cerny, T. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1343-8 · Cited by 17
Gürkan, S., Seber, S., Gür, Ö., Yetişyiğit, T., Donbaloğlu, M. O., & Gür, D. Ö. (2015) · PubMed · Cited by 17
Heidari, Z., Mahmoudzadeh‐Sagheb, H., Jahantigh, M., & Gorgich, E. A. C. (2017) · International Journal of Cancer Management · doi:10.5812/ijcm.12252 · Cited by 17
Hong, C., Allred, R., Napeñas, J. J., Brennan, M. T., Baddour, L. M., & Lockhart, P. B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.08.009 · Cited by 17
Dickinson, M. G., Schölvinck, E. H., Boonstra, A., Noordegraaf, A. V., Snijder, R. J., & Berger, R. M. F. (2009) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.11.913 · Cited by 17
Association between Periprocedural Neutropenia and Early Infection-related Chest Port Removal
Perez, A. W., Watchmaker, J. M., Brown, D. B., & Banovac, F. (2019) · Radiology · doi:10.1148/radiol.2019182175 · Cited by 16
Inoue, Y., & Kusunoki, M. (2013) · Surgery Today · doi:10.1007/s00595-013-0672-8 · Cited by 16
Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs)
Rasero, L., Golin, L., Ditta, S., Massimo, D. S. D., Molin, A. D., & Piemonte, G. (2018) · British Journal of Nursing · doi:10.12968/bjon.2018.27.8.s4 · Cited by 16
Sawayama, H., Hayashi, N., Watanabe, M., Takamori, H., Beppu, T., & Baba, H. (2011) · Surgery Today · doi:10.1007/s00595-011-0016-5 · Cited by 15
The Management of Totally Implanted Venous Ports in the Ambulatory Oncologic Patient
Molin, A. D., Guerretta, L., Mazzufero, F., & Rasero, L. (2009) · The Journal of Vascular Access · doi:10.1177/112972980901000104 · Cited by 15
Standard Operating Procedures (SOP)
Engelhardt, R., Engelhardt, A., Gärtner, F., Mielke, S., & Frank, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-73277-8_10 · Cited by 15
Haag, G.-M., Berger, A.-K., & Jäger, D. (2011) · The Journal of Vascular Access · doi:10.5301/jva.2011.6265 · Cited by 15
Metadata
- Authors
- Vescia, S., Baumgärtner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., & Harbeck, N.
- Affiliations
- German Breast Group (DE)
- TUM Klinikum (DE)
- University Hospital Frankfurt (DE)
- Corresponding author
- Baumgärtner, A.K.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 19
- Issue
- 1
- Pages
- 9-15
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2150240326
- Cited by
- 264
- References
- 56
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 21 · 2017: 14 · 2016: 17 · 2015: 8 · 2014: 21 · 2013: 12 · 2012: 20
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- central venous catheters, catheter-related infection, catheter-related thrombosis, thromboprophylaxis, low molecular weight heparin, warfarin, port maintenance, infection prevention guidelines
- MeSH terms
- Anticoagulants, Antineoplastic Agents, Catheterization, Central Venous, Catheters, Indwelling, Clinical Trials as Topic, Equipment Contamination, Humans, Neoplasms, Thromboembolism, Fungemia, Bacteremia, Infection Control, Antibiotic Prophylaxis, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
